Teva Pharmaceutical Industries Ltd. (TEVA)
37.09
+0.74
(+2.04%)
USD |
NYSE |
Sep 11, 16:00
37.38
+0.29
(+0.78%)
After-Hours: 20:00
Teva Pharmaceutical Industries Price : 37.09 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 36.46 | 37.11 | 36.06 | 37.09 | 2.855M |
| Sep 10, 2026 | 36.37 | 36.75 | 36.04 | 36.35 | 4.014M |
| Sep 09, 2026 | 36.82 | 37.32 | 36.47 | 36.85 | 4.000M |
| Sep 08, 2026 | 35.89 | 36.96 | 35.42 | 36.76 | 4.624M |
| Sep 04, 2026 | 36.40 | 36.93 | 36.13 | 36.36 | 7.403M |
| Sep 03, 2026 | 37.98 | 38.06 | 36.33 | 36.62 | 3.905M |
| Sep 02, 2026 | 36.65 | 37.59 | 35.74 | 37.49 | 7.690M |
| Sep 01, 2026 | 36.52 | 36.55 | 35.85 | 36.19 | 3.516M |
| Aug 31, 2026 | 36.17 | 36.33 | 35.62 | 36.05 | 5.779M |
| Aug 28, 2026 | 37.37 | 37.42 | 36.37 | 36.44 | 3.141M |
| Aug 27, 2026 | 37.72 | 38.37 | 37.54 | 37.62 | 4.722M |
| Aug 26, 2026 | 37.70 | 38.06 | 37.07 | 37.92 | 4.816M |
| Aug 25, 2026 | 37.13 | 38.11 | 37.09 | 38.10 | 5.279M |
| Aug 24, 2026 | 37.30 | 37.32 | 36.75 | 36.93 | 3.339M |
| Aug 21, 2026 | 36.79 | 37.75 | 36.65 | 37.34 | 4.300M |
| Aug 20, 2026 | 37.12 | 37.34 | 36.74 | 36.81 | 4.513M |
| Aug 19, 2026 | 37.00 | 37.83 | 36.60 | 37.47 | 7.976M |
| Aug 18, 2026 | 36.47 | 37.25 | 36.34 | 36.58 | 6.198M |
| Aug 17, 2026 | 36.53 | 36.78 | 35.99 | 36.46 | 3.585M |
| Aug 14, 2026 | 36.26 | 36.81 | 36.09 | 36.77 | 2.333M |
| Aug 13, 2026 | 36.90 | 37.39 | 36.46 | 36.52 | 7.609M |
| Aug 12, 2026 | 36.80 | 37.24 | 36.44 | 36.74 | 5.701M |
| Aug 11, 2026 | 36.17 | 36.98 | 36.13 | 36.48 | 8.041M |
| Aug 10, 2026 | 35.03 | 36.14 | 35.00 | 36.14 | 5.608M |
| Aug 07, 2026 | 35.00 | 35.77 | 34.87 | 35.36 | 4.272M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1115.70 |
| Bristol Myers Squibb Co. | 63.64 |
| RedHill Biopharma Ltd. | 0.6449 |
| Johnson & Johnson | 265.58 |
| MediWound Ltd. | 13.11 |
Price Related Metrics
| PE Ratio | 62.37 |
| PS Ratio | 2.487 |
| Price to Book Value | 5.573 |
| Price to Free Cash Flow | 29.56 |
| Earnings Yield | 1.60% |
| Market Cap | 43.21B |
| Operating PE Ratio | 13.24 |
| Normalized PE Ratio | 23.37 |